Goldman Sachs
QGENF

Goldman Sachs’s QIAGEN NV QGENF Stock Holding History

Goldman Sachs’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,729,001
Closed -$48.4M – 7307
2016
Q4 		$48.4M Buy
1,729,001
+9,175
+0.5% +$257K 0.01% 1289
2016
Q3 		$47.2M Buy
1,719,826
+549,982
+47% +$15.1M 0.01% 1256
2016
Q2 		$25.5M Sell
1,169,844
-278,988
-19% -$6.08M 0.01% 1614
2016
Q1 		$32.4M Buy
1,448,832
+549,170
+61% +$12.3M 0.01% 1369
2015
Q4 		$24.9M Buy
899,662
+157,644
+21% +$4.36M 0.01% 1597
2015
Q3 		$19.1M Buy
742,018
+90,453
+14% +$2.33M 0.01% 1744
2015
Q2 		$16.2M Sell
651,565
-34,266
-5% -$849K 0.01% 1956
2015
Q1 		$17.3M Sell
685,831
-192,640
-22% -$4.85M 0.01% 1859
2014
Q4 		$20.6M Buy
878,471
+116,638
+15% +$2.74M 0.01% 1799
2014
Q3 		$17.3M Sell
761,833
-55,513
-7% -$1.26M 0.01% 1903
2014
Q2 		$20M Buy
817,346
+517,977
+173% +$12.7M 0.01% 1783
2014
Q1 		$6.31M Sell
299,369
-19,106
-6% -$403K ﹤0.01% 2766
2013
Q4 		$7.58M Sell
318,475
-285,826
-47% -$6.8M ﹤0.01% 2624
2013
Q3 		$12.9M Sell
604,301
-236,841
-28% -$5.07M ﹤0.01% 1984
2013
Q2 		$16.7M Buy
+841,142
New +$16.7M 0.01% 1666

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Goldman Sachs's QGENF Position: Q1 2017 in Review

Goldman Sachs sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 1,729,001 shares — an estimated $48.4M sold.

Goldman Sachs first reported a position in QGENF in Q2 2013 and held it in 15 quarters. The position peaked at $48.4M in Q4 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Goldman Sachs reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Goldman Sachs sold 1,729,001 QIAGEN NV shares in Q1 2017, an estimated $48.4M.
  • Goldman Sachs first reported a position in QIAGEN NV in Q2 2013 and held it in 15 quarters.
  • Goldman Sachs's QIAGEN NV position peaked at $48.4M in Q4 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Goldman Sachs's 13F filing for Q1 2017, filed 15 May 2017.